These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms. Jespers W; Schiedel AC; Heitman LH; Cooke RM; Kleene L; van Westen GJP; Gloriam DE; Müller CE; Sotelo E; Gutiérrez-de-Terán H Trends Pharmacol Sci; 2018 Jan; 39(1):75-89. PubMed ID: 29203139 [TBL] [Abstract][Full Text] [Related]
3. Alternative quality assessment strategy to compare performances of GPCR-ligand docking protocols: the human adenosine A(2A) receptor as a case study. Ciancetta A; Cuzzolin A; Moro S J Chem Inf Model; 2014 Aug; 54(8):2243-54. PubMed ID: 25046649 [TBL] [Abstract][Full Text] [Related]
6. Medicinal chemistry of adenosine, P2Y and P2X receptors. Jacobson KA; Müller CE Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393 [TBL] [Abstract][Full Text] [Related]
7. Recent Updates in the Computer Aided Drug Design Strategies for the Discovery of Agonists and Antagonists of Adenosine Receptors. Deb PK Curr Pharm Des; 2019; 25(7):747-749. PubMed ID: 31232230 [No Abstract] [Full Text] [Related]
8. Medicinal chemistry of adenosine A1 receptor ligands. Soudijn W; van Wijngaarden I; IJzerman AP Curr Top Med Chem; 2003; 3(4):355-67. PubMed ID: 12570755 [TBL] [Abstract][Full Text] [Related]
9. Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs). Jacobson KA Bioconjug Chem; 2009 Oct; 20(10):1816-35. PubMed ID: 19405524 [TBL] [Abstract][Full Text] [Related]
10. Adenosine receptor desensitization and trafficking. Mundell S; Kelly E Biochim Biophys Acta; 2011 May; 1808(5):1319-28. PubMed ID: 20550943 [TBL] [Abstract][Full Text] [Related]
11. Limits of ligand selectivity from docking to models: in silico screening for A(1) adenosine receptor antagonists. Kolb P; Phan K; Gao ZG; Marko AC; Sali A; Jacobson KA PLoS One; 2012; 7(11):e49910. PubMed ID: 23185482 [TBL] [Abstract][Full Text] [Related]
12. Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathways. Agarwal R; Agarwal P Expert Opin Ther Targets; 2014 May; 18(5):527-39. PubMed ID: 24579961 [TBL] [Abstract][Full Text] [Related]
13. Theoretical structure-activity studies of adenosine A1 ligands: requirements for receptor affinity. Dooley MJ; Kono M; Suzuki F Bioorg Med Chem; 1996 Jun; 4(6):923-34. PubMed ID: 8818243 [TBL] [Abstract][Full Text] [Related]
14. Pharmacophoric models and 3D QSAR studies of the adenosine receptor ligands. Tintori C; Manetti F; Botta M Curr Top Med Chem; 2010; 10(10):1019-35. PubMed ID: 20370655 [TBL] [Abstract][Full Text] [Related]
15. Molecular modeling the human A1 adenosine receptor and study of the mechanisms of its selective ligand binding. Ivanov AA; Baskin II; Palyulin VA; Zefirov NS Dokl Biochem Biophys; 2002; 386():271-4. PubMed ID: 12469507 [No Abstract] [Full Text] [Related]
16. Adenosine A2A receptor agonists: CoMFA-based selection of the most predictive conformation. Doytchinova I; Valkova I; Natcheva R SAR QSAR Environ Res; 2002 Mar; 13(2):227-35. PubMed ID: 12071651 [TBL] [Abstract][Full Text] [Related]
17. Nomenclature and classification of purinoceptors. Fredholm BB; Abbracchio MP; Burnstock G; Daly JW; Harden TK; Jacobson KA; Leff P; Williams M Pharmacol Rev; 1994 Jun; 46(2):143-56. PubMed ID: 7938164 [No Abstract] [Full Text] [Related]
18. Application of Fluorescent Purinoceptor Antagonists for Bioluminescence Resonance Energy Transfer Assays and Fluorescent Microscopy. Soave M; Goulding J; Markus R; Hill SJ; Stoddart LA Methods Mol Biol; 2020; 2041():163-181. PubMed ID: 31646488 [TBL] [Abstract][Full Text] [Related]
19. Multi-objective evolutionary design of adenosine receptor ligands. van der Horst E; Marqués-Gallego P; Mulder-Krieger T; van Veldhoven J; Kruisselbrink J; Aleman A; Emmerich MT; Brussee J; Bender A; Ijzerman AP J Chem Inf Model; 2012 Jul; 52(7):1713-21. PubMed ID: 22647079 [TBL] [Abstract][Full Text] [Related]
20. The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells. Kudlacek O; Just H; Korkhov VM; Vartian N; Klinger M; Pankevych H; Yang Q; Nanoff C; Freissmuth M; Boehm S Neuropsychopharmacology; 2003 Jul; 28(7):1317-27. PubMed ID: 12784121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]